5.45

0.37% +0.02

After Hours: 5.63 0.18 +3.30%

CalciMedica Inc (CALC)

Overview News Price History Discussions Forecast Stock Split

CalciMedica Inc stock is currently priced at $5.45, with a 24-hour trading volume of 55,926. It has seen a +0.37% increased in the last 24 hours and a +25.58% rose in the past month. The chart indicates a potential bearish trend, as the stock is below the $5.55 pivot point. If it approaches the $5.29 support level, significant changes may occur.

Previous Close:

$5.43

Open:

$5.51

24h Volume:

55,926

Market Cap:

$58.58M

Revenue:

Net Income/Loss:

$-34.36M

P/E Ratio:

-0.1525

EPS:

-35.74

Net Cash Flow:

$-25.81M

1W Performance:

-2.68%

1M Performance:

+25.58%

6M Performance:

+56.61%

1Y Performance:

+0.00%

1D Range:

$5.45

$5.90

52W Range:

$1.75

$8.38

CalciMedica Inc Stock (CALC) Company Profile

Name

CalciMedica Inc

Sector

Healthcare (1209)

Industry

Biotechnology (699)

Phone

858-952-5500

Address

505 Coast Boulevard South, Suite 202, La Jolla

Employee

Twitter

Next Earnings Date

2024-05-13

Latest SEC Filings

CALC's Discussions on Twitter

CalciMedica Inc Stock (CALC) Latest News

HC Wainwright Comments on CalciMedica, Inc.'s FY2024 Earnings (NASDAQ:CALC) - MarketBeat

MarketBeat

(CALC) Investment Analysis - Stock Traders Daily

Stock Traders Daily

CalciMedica, Inc. to Post Q2 2024 Earnings of ($0.42) Per Share, HC Wainwright Forecasts (NASDAQ:CALC) - Defense World

Defense World

HC Wainwright Brokers Raise Earnings Estimates for CalciMedica, Inc. (NASDAQ:CALC) - MarketBeat

MarketBeat

CalciMedica's (CALC) “Buy” Rating Reaffirmed at HC Wainwright - Defense World

Defense World

HC Wainwright Reaffirms Buy Rating for CalciMedica (NASDAQ:CALC) - MarketBeat

MarketBeat

CalciMedica Inc Stock (CALC) Financials Data

CalciMedica Inc (CALC) Net Income 2024

CALC net income (TTM) was -$34.36 million for the quarter ending December 31, 2023, a -339.12% decrease year-over-year.

CalciMedica Inc (CALC) Cash Flow 2024

CALC recorded a free cash flow (TTM) of -$25.81 million for the quarter ending December 31, 2023, a -119.44% decrease year-over-year.

CalciMedica Inc (CALC) Earnings per Share 2024

CALC earnings per share (TTM) was -$330.31 for the quarter ending December 31, 2023, a +72.17% growth year-over-year.

CalciMedica, Inc., a clinical-stage biotechnology company, focuses on developing therapies for life-threatening inflammatory diseases with unmet needs. Its proprietary technology targets the inhibition of calcium release-activated (CRAC) channels designs to modulate the immune response and protect against tissue cell injury in life-threatening inflammatory diseases. Its lead product candidate is Auxora, a proprietary intravenous-formulated CRAC channel inhibitor for the treatment of acute pancreatitis, asparaginase-associated acute pancreatitis, and acute kidney injury. The company is based in La Jolla, California.